References
1. Najafi A, Chaechi Nosrati MR, Ghasemi E, Navi Z, Yousefi A, Majidiani
H, et al. Is there association between Trichomonas vaginalis infection
and prostate cancer risk?: A systematic review and meta-analysis.
Microbial pathogenesis. 2019;137:103752.
2. Edwards T, Burke P, Smalley H, Hobbs G. Trichomonas vaginalis:
Clinical relevance, pathogenicity and diagnosis. Crit Rev Microbiol.
2016;42(3):406-17.
3. Krieger JN. Trichomoniasis in Men: Old Issues and New Data. Sexually
Transmitted Diseases. 1995;22(2):83-96.
4. Kandamuthan S, Thambi R, Yeshodharan J. Trichomoniasis: Is it always
sexually transmitted? Indian J Sex Transm Dis AIDS. 2014;35(2):166-7.
5. Mercer F, Johnson PJ. Trichomonas vaginalis: Pathogenesis, Symbiont
Interactions, and Host Cell Immune Responses. Trends Parasitol.
2018;34(8):683-93.
6. Van Gerwen OT, Camino AF, Sharma J, Kissinger PJ, Muzny CA.
Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas
vaginalis in Men. Clin Infect Dis. 2021;73(6):1119-24.
7. Maeda S, Kubota Y, Senda Y, Tamaki M, Yasuda M, Deguchi T. Failure to
detect urethral Trichomonas vaginalis in Japanese men with or without
urethritis. Int J Urol. 2006;13(11):1418-20.
8. Kissinger PJ, Gaydos CA, Seña AC, Scott McClelland R, Soper D, Secor
WE, et al. Diagnosis and Management of Trichomonas vaginalis: Summary of
Evidence Reviewed for the 2021 Centers for Disease Control and
Prevention Sexually Transmitted Infections Treatment Guidelines. Clin
Infect Dis. 2022;74(Suppl_2):S152-s61.
9. Han IH, Kim JH, Ryu JS. Inflammatory response to Trichomonas
vaginalis in the pathogenesis of prostatitis and benign prostatic
hyperplasia. Parasites Hosts Dis. 2023;61(1):2-14.
10. Momeni Z, Sadraei J, Kazemi B, Dalimi A. Trichomoniasis in older
individuals: a preliminary report from Iran. J Parasit Dis.
2016;40(4):1597-600.
11. Lindrose AR, Htet KZ, O’Connell S, Marsh J, Kissinger PJ. Burden of
trichomoniasis among older adults in the United States: a systematic
review. Sex Health. 2022;19(3):151-6.